More recent large scale comparative analyses of gene expression patterns in >2000 cases of DLBCL identified Bright/ARID3a as a member of a family of transcription factor signature genes consistently associated with ABC DLBCL, suggesting it might be a useful marker for identification of this subset of lymphoma (66). This evidence concerns the gene ARID3A and diffuse large B-cell lymphoma.